Glynase

Glynase is a brand name of glyburide, approved by the FDA in the following formulation(s):

GLYNASE (glyburide - tablet; oral)

• 
  Manufacturer: PHARMACIA AND UPJOHN
  
  Approval date: March 4, 1992
  
  Strength(s): 1.5MG ^[AB], 3MG ^[AB]


• 
  Manufacturer: PHARMACIA AND UPJOHN
  
  Approval date: September 24, 1993
  
  Strength(s): 6MG ^[RLD][AB]

Has a generic version of Glynase been approved?

Yes. The following products are equivalent to Glynase:

GLYBURIDE (MICRONIZED) (glyburide tablet; oral)

• 
  Manufacturer: DAVA PHARMS INC
  
  Approval date: December 22, 1997
  
  Strength(s): 1.5MG ^[AB], 3MG ^[AB], 6MG ^[AB]


• 
  Manufacturer: HIKMA
  
  Approval date: July 31, 2003
  
  Strength(s): 1.5MG ^[AB], 3MG ^[AB], 6MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: June 26, 1998
  
  Strength(s): 1.5MG ^[AB], 3MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: August 17, 1999
  
  Strength(s): 6MG ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: April 20, 1999
  
  Strength(s): 1.5MG ^[AB], 3MG ^[AB], 6MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Glynase. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Glynase.

See also...

• Glynase Tablets (Micronized) Consumer Information (Wolters Kluwer)
• Glyburide Consumer Information (Drugs.com)
• Glyburide Consumer Information (Wolters Kluwer)
• Glyburide Tablets (Micronized) Consumer Information (Wolters Kluwer)
• Glyburide Consumer Information (Cerner Multum)
• Euglucon Advanced Consumer Information (Micromedex)
• Glyburide Advanced Consumer Information (Micromedex)
• Glyburide AHFS DI Monographs (ASHP)